Anti-Cystatin-B antibody [EPR3931] - BSA and Azide free
- RabMAb
- Recombinant
- KO Validated
- What is this?
Be the first to review this product! Submit a review
|
(1 Publication)
Rabbit Recombinant Monoclonal Cystatin-B antibody. Carrier free. Suitable for IHC-P, WB and reacts with Human samples. Cited in 1 publication.
View Alternative Names
CST6, STFB, CSTB, Cystatin-B, CPI-B, Liver thiol proteinase inhibitor, Stefin-B
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Cystatin-B antibody [EPR3931] - BSA and Azide free (AB247554)
This data was developed using ab92449, the same antibody clone in a different buffer formulation.
ab92449, at 1/100 dilution, staining Cystatin-B in paraffin-embedded Human colon tissue.
Heat mediated antigen retrieval was performed before commencing with IHC staining protocol.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Cystatin-B antibody [EPR3931] - BSA and Azide free (AB247554)
This data was developed using ab92449, the same antibody clone in a different buffer formulation.
ab92449, at 1/100 dilution, staining Cystatin-B in paraffin-embedded Human kidney tissue.
Heat mediated antigen retrieval was performed before commencing with IHC staining protocol.
- WB
Unknown
Western blot - Anti-Cystatin-B antibody [EPR3931] - BSA and Azide free (AB247554)
This data was developed using ab92449, the same antibody clone in a different buffer formulation.
All lanes:
Western blot - Anti-Cystatin-B antibody [EPR3931] (<a href='/en-us/products/primary-antibodies/cystatin-b-antibody-epr3931-ab92449'>ab92449</a>) at 1/1000 dilution
Lane 1:
U-87 MG (Human glioblastoma-astrocytoma epithelial cell line) cell lysate at 10 µg
Lane 2:
JAR cell lysate at 10 µg
Lane 3:
Human bladder tissue lysate at 10 µg
Secondary
All lanes:
HRP labelled goat anti-rabbit at 1/2000 dilution
Predicted band size: 11 kDa
false
- WB
Lab
Western blot - Anti-Cystatin-B antibody [EPR3931] - BSA and Azide free (AB247554)
This data was developed using ab92449, the same antibody clone in a different buffer formulation.
Lanes 1-4 : Merged signal (red and green). Green - ab92449 observed at 15 kDa. Red - loading control ab8245 observed at 36 kDa.
ab92449 Anti-Cystatin-B antibody [EPR3931] was shown to specifically react with Cystatin-B in wild-type HEK293T cells. Loss of signal was observed when knockout cell line ab266321 (knockout cell lysate ab257905) was used. Wild-type and Cystatin-B knockout samples were subjected to SDS-PAGE. ab92449 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated overnight at 4°C at 1 in 1000 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-Cystatin-B antibody [EPR3931] (<a href='/en-us/products/primary-antibodies/cystatin-b-antibody-epr3931-ab92449'>ab92449</a>) at 1/1000 dilution
Lane 1:
Wild-type HEK293T cell lysate at 20 µg
Lane 2:
CSTB knockout HEK293T cell lysate at 20 µg
Lane 2:
Western blot - Human CSTB (Cystatin-B) knockout HEK-293T cell line (<a href='/en-us/products/cell-lines/human-cstb-cystatin-b-knockout-hek-293t-cell-line-ab266321'>ab266321</a>)
Lane 3:
U87-MG cell lysate at 20 µg
Lane 4:
JAR cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-irdye-800cw-preadsorbed-ab216773'>ab216773</a>) at 1/10000 dilution
Predicted band size: 11 kDa
Observed band size: 15 kDa
false
Related conjugates and formulations (1)
-
Anti-Cystatin-B antibody [EPR3931]
Reactivity data
Product details
ab247554 is the carrier-free version of ab92449.
Species reactivity
Mouse: We have preliminary internal testing data to indicate this antibody may not react with this species.
Please contact us for more information.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Cysteine protease inhibition by Cystatin-B protects cells from uncontrolled proteolysis which can lead to tissue damage. This protein plays an important role in the regulation of various cellular processes including apoptosis phagocytosis and the response to oxidative stress. It does not form part of a larger complex but interacts directly with its target proteases to exert its inhibitory effects.
Pathways
Cystatin-B influences proteolytic pathways by modulating the activity of cysteine proteases such as cathepsins. By inhibiting these enzymes Cystatin-B participates in the regulation of the lysosomal degradation pathway and apoptotic pathways which are important for cellular turnover and programmed cell death. Cathepsins particularly cathepsin B and L are related proteins that are significantly modulated through their interaction with Cystatin-B.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
Obesity (Silver Spring, Md.) 30:666-679 PubMed35170865
2022
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com